Hospice Care in America
Hospice care is a specialized form of medical care designed not to cure disease but to prioritize comfort, dignity, and quality of life for people who are terminally ill and expected to live six months or less — assuming their illness runs its natural course. It is a holistic model of care that addresses not just the physical symptoms of dying — pain, breathlessness, nausea, anxiety — but the emotional, spiritual, and practical needs of both the patient and their family. In the United States, hospice is not a place but a philosophy of care that can be delivered at home, in nursing facilities, in dedicated inpatient hospice facilities, or in hospitals. The care is typically provided by an interdisciplinary team that includes physicians, nurses, social workers, chaplains, home health aides, and volunteers, all working together under a unified plan directed by the patient’s goals rather than by any curative agenda. Under the Medicare Hospice Benefit — established by Congress in 1982 and administered by the Centers for Medicare & Medicaid Services (CMS) — Medicare covers virtually all hospice costs for eligible beneficiaries who elect it, making it one of the most comprehensively covered medical services in the entire Medicare program.
What makes hospice care in America in 2026 such an urgent and growing topic is the combination of demographic momentum and persistent access inequity that together define the current landscape. In 2024, a historic milestone was crossed: for the first time ever, the majority of Medicare decedents died while enrolled in hospice — a landmark confirmation that this model of care has moved from a niche alternative to the mainstream endpoint of American medical life for older adults. Yet even as utilization reaches historic levels, stark disparities in who accesses hospice — by race, geography, and socioeconomic status — remain deeply embedded in the system. The National Alliance for Care at Home’s 2025 Facts and Figures report — released in March 2026 and covering calendar year 2024 data — is the definitive current source on this field, and it paints a picture of a sector that is simultaneously succeeding by its own metrics and falling short of its potential to serve all Americans equally.
Interesting Facts About Hospice Care in the US 2026
HOSPICE CARE FAST FACTS — US 2026
====================================
Medicare beneficiaries enrolled in hospice (2024) ████████████████████ 1.91 Million
Died while enrolled in hospice (2024) ████████████████████ 1.3 Million
% of Medicare decedents in hospice — HISTORIC ████████████████████ MAJORITY (first time)
Medicare hospice payment rate increase (FY2026) ████████████████████ +2.6% ($750M added)
Home-based hospice care — share (2023/2024) ████████████████████ ~66%
Live discharge rate (FY2024) ████████████████████ 19.0%
For-profit hospice avg. length of stay ████████████████████ 187 days
Nonprofit hospice avg. length of stay ████████████████████ 130 days
Scale: Each █ ≈ ~5 percentage points or proportional units
| Fact | Statistic / Detail |
|---|---|
| Medicare beneficiaries enrolled in hospice (2024) | 1.91 million — a 4.4% increase from 2023 (National Alliance for Care at Home, 2025 Facts and Figures, March 2026) |
| Medicare beneficiaries who died in hospice (2024) | 1.3 million died while enrolled in hospice care (National Alliance, March 2026) |
| Historic milestone (2024) | For the first time in history, the majority of Medicare decedents were enrolled in hospice at time of death (National Alliance, 2025 Facts and Figures) |
| FY2026 Medicare hospice payment rate increase | +2.6% — an estimated $750 million increase from FY2025 payments (CMS Final Rule CMS-1835-F, August 1, 2025) |
| FY2026 rate calculation | 3.3% market basket percentage minus 0.7% productivity adjustment = +2.6% (CMS) |
| Home-based hospice — share of settings (2023/2024) | Approximately 66% of hospice patients receive care at home (Rosewood Nursing, March 2025) |
| Average length of stay — for-profit hospices | 187 days — significantly longer than nonprofit counterparts (MedPAC March 2025 Report to Congress) |
| Average length of stay — nonprofit hospices | 130 days (MedPAC March 2025 Report to Congress) |
| Average length of stay — Medicare patients (2022) | 95.3 days overall average; median is far shorter — indicating very short stays by many patients (NHPCO/Statista, 2024) |
| Live discharge rate (FY2024) | 19.0% — up from 16.0% in FY2020 — steady increase over 4 years (CMS Hospice Monitoring Report, April 2025) |
| Hospice spending savings — when LOS exceeds 15 days | Total cost of care for hospice users was lower than non-hospice users once stay exceeded 15 days (NHPCO/Statista, 2023 study) |
| Racial disparity — hospice use | Only 1 in 3 Black Medicare participants utilize hospice vs. nearly 1 in 2 White beneficiaries |
| Cancer and circulatory disease — share of diagnoses | Account for nearly three-quarters of all hospice beneficiary diagnoses (Medicare data, 2022; AHR 2026) |
| Most prevalent diagnoses in hospice (2022) | Dementia and Alzheimer’s disease — the most prevalent individual diagnoses (Medicare/CMS data) |
| Hospice programs certified by CMS | Approximately 93% of US hospice programs are CMS-certified (NHPCO Facts and Figures) |
| Medicare decedents in hospice — women vs. men | Women more likely than men to use hospice — gender disparity documented in Medicare data |
| Medicare hospice benefit established | 1982 — over four decades of federal coverage for end-of-life care |
| Adults 85+ vs. younger beneficiaries | Adults aged 85 and older more likely to use hospice than younger Medicare beneficiaries (AHR 2026) |
Source: National Alliance for Care at Home — 2025 Facts and Figures Executive Summary (published March 3, 2026; covering calendar year 2024 CMS data); CMS — FY 2026 Hospice Wage Index and Payment Rate Update Final Rule (CMS-1835-F; published Federal Register August 5, 2025); CMS — Hospice Monitoring Report April 2025 (covering FYs 2020–2024); MedPAC — March 2025 Report to Congress, Chapter 9: Hospice Services; America’s Health Rankings — Explore Hospice Care in the United States (accessed 2026, citing NHPCO Facts and Figures 2024 edition); NHPCO/Statista — Average and Median Length of Stay for Medicare Hospice Patients 2015–2022 (Statista, retrieved February 27, 2026)
The 1.91 million Medicare beneficiaries enrolled in hospice in 2024 — a 4.4% year-over-year increase — represents the highest single-year enrollment ever recorded and confirms that hospice has become a mainstream feature of end-of-life care for American seniors. The historic milestone that the majority of Medicare decedents died while enrolled in hospice, documented in the National Alliance for Care at Home’s March 2026 report, marks a generational shift in how America dies: for the first time, the default pathway for older Americans at the end of life has become one that prioritizes comfort over intervention. This is a profound cultural and clinical achievement that reflects decades of advocacy, education, and policy investment in the hospice model. The CMS Final Rule issued August 1, 2025 locking in a 2.6% payment rate increase for FY2026 — translating to approximately $750 million in additional Medicare payments — signals that the federal government recognizes hospice’s critical role and is committed to maintaining its financial viability.
The live discharge rate of 19.0% in FY2024 — up from 16.0% in FY2020, a steady climb over four years tracked by the CMS Hospice Monitoring Report — is one of the most watched and debated metrics in the field. A live discharge occurs when a patient leaves hospice care alive — either because their condition improved, their prognosis changed, or they chose to pursue curative treatment again. The steady rise in live discharges has two interpretations: optimistically, it reflects better prognostication and earlier hospice enrollment, meaning more patients enter while still relatively healthy and some genuinely stabilize; more critically, it has been associated by MedPAC and other researchers with for-profit hospice practices that may enroll patients with longer prognoses to maximize payment days, then discharge them before death occurs. The stark difference between for-profit hospices averaging 187 days per patient versus nonprofit hospices averaging 130 days in MedPAC’s own analysis gives this concern empirical weight.
Hospice Care Costs & Medicare Coverage in the US 2026
HOSPICE CARE COSTS & MEDICARE COVERAGE — US 2026
=================================================
FY2026 Medicare hospice payment increase ████████████████████ +2.6% / +$750M
Home/continuous home care daily rate ████████████████████ ~$200–$220/day (routine)
Inpatient respite care (per day, approx.) ████████████████████ ~$475/day (Medicare)
Continuous home care (crisis, per day) ████████████████████ ~$1,500/day
General inpatient care (per day, approx.) ████████████████████ ~$1,000/day
Patient cost-sharing for drugs/aids ████████████ <5% of drug cost; ≤$5/drug
Patient cost-sharing for inpatient respite ████████████ 5% of Medicare rate
Annual hospice aggregate cap (FY2026) ████████████████████ Updated per CMS rule
Scale: Each █ ≈ proportional / illustrative
| Cost / Coverage Metric | Statistic / Data |
|---|---|
| Medicare Hospice Benefit coverage | Covers physician services, nursing, social work, spiritual care, aide services, medications for comfort, medical equipment, and bereavement counseling |
| Patient cost-sharing — drugs | Patient pays up to $5 per drug for symptom-control medications; no charge for most drugs |
| Patient cost-sharing — inpatient respite | 5% of the Medicare-approved payment amount for inpatient respite care |
| Patient cost-sharing — all other hospice services | Zero — Medicare covers 100% of approved costs |
| FY2026 payment rate increase | +2.6% from FY2025 — estimated $750 million increase total (CMS CMS-1835-F Final Rule) |
| FY2026 rate rationale | 3.3% inpatient hospital market basket minus 0.7% productivity adjustment (CMS) |
| FY2026 rule alignment | Hospice rule aligned with FY2026 IPPS final rule rebasing to a 2023 base year (CMS) |
| Medicare hospice aggregate cap | Updated annually per CMS rule — limits total payments per hospice per patient |
| For-profit hospice average margin | Higher than nonprofit — driven largely by patient mix and length of stay differences (MedPAC 2025) |
| Medicare hospice vs. non-hospice spending | Hospice total care cost lower than non-hospice once stay exceeds 15 days — Statista/NHPCO study |
| Short stays (≤15 days) | Do not generate Medicare savings for most conditions — exception: neurodegenerative disorders |
| Half of hospice stays | Are 18 days or less — meaning roughly half of patients enroll too late to generate savings (Statista/NHPCO, 2023 study) |
| Spending on hospice — two decades | Has skyrocketed over past two decades as utilization has grown (AHR 2026, CMS data) |
| Continuous home care (crisis care) rate | Highest-intensity home care level — for crisis periods requiring near-continuous nursing |
| Medicaid hospice rates — FY2025 | State-specific rates vary; FY2025 Medicaid rates published by CMS |
| Election requirement — Medicare | Patient must agree to forgo all curative treatment for the terminal diagnosis to elect hospice benefit — a barrier to earlier enrollment (AHR 2026) |
Source: CMS — FY 2026 Hospice Wage Index and Payment Rate Update Final Rule CMS-1835-F (August 1, 2025; Federal Register August 5, 2025); CMS — Medicare Hospice Benefit coverage description (Medicare.gov); CMS Hospice Monitoring Report April 2025 (FY2020–FY2024); MedPAC — March 2025 Report to Congress, Chapter 9; Statista/NHPCO — Total cost of care difference, hospice vs. non-hospice (2023 study, accessed February 25, 2026)
The Medicare Hospice Benefit is one of the most comprehensive coverage packages in the entire Medicare program — and for enrolled patients, it is essentially zero-cost beyond a $5 maximum per drug for symptom-control medications and a 5% copayment for inpatient respite care. Everything else — the nursing visits, physician oversight, social work, spiritual care, home health aide support, durable medical equipment, and bereavement counseling for the family — is covered at 100%. This extraordinary coverage package is exactly why the election decision is so consequential: patients must agree to forgo all curative treatment for their terminal diagnosis to access it, a requirement that America’s Health Rankings identifies as a documented barrier to earlier enrollment for patients who are still hoping for a cure or whose families are not ready to accept a terminal prognosis.
The FY2026 CMS Final Rule published August 1, 2025 — one of the most current pieces of hospice policy in existence as of this writing — provides the framework within which hospice providers operate financially in 2026. The 2.6% payment increase, calculated as the 3.3% inpatient market basket rate minus the 0.7% productivity adjustment, adds an estimated $750 million in total Medicare hospice payments compared to FY2025. The rule also includes important regulatory clarifications: it formalizes that physician members of the interdisciplinary group may recommend admission to hospice care, aligns with the IPPS market basket rebasing to a 2023 base year, and adds flexibility to face-to-face encounter documentation requirements. These regulatory details matter enormously for the roughly 5,000+ CMS-certified hospice providers operating across the country, whose financial stability and clinical staffing decisions are directly shaped by these annual rule updates.
Hospice Care Demographics & Access Disparities in the US 2026
HOSPICE ACCESS BY DEMOGRAPHICS — US 2026
==========================================
White Medicare beneficiaries — hospice use ████████████████████ ~50% of decedents
Black Medicare beneficiaries — hospice use ████████████ ~33% (1 in 3)
Women vs. men — hospice utilization ████████████████████ Women more likely
Adults 85+ vs. younger beneficiaries ████████████████████ 85+ most likely to use
Home-based care (2023/2024) ████████████████████ ~66% of patients
For-profit hospice LOS ████████████████████ 187 days (avg)
Nonprofit hospice LOS ████████████ 130 days (avg)
Dementia/Alzheimer's — primary diagnosis ████████████████████ Most prevalent type
Scale: Each █ ≈ ~5 percentage points or proportional
| Demographic / Access Metric | Statistic / Data |
|---|---|
| White Medicare beneficiaries — hospice use | Nearly 50% of White Medicare decedents enrolled in hospice — among the highest utilization rates |
| Black Medicare beneficiaries — hospice use | Only 1 in 3 Black Medicare participants utilizes hospice — a persistent and significant disparity |
| Documented reasons for Black underutilization | Mistrust due to racism, fear of inadequate care, and lack of knowledge about hospice and palliative care (AHR 2026, citing research) |
| Gender — hospice use | Women more likely than men to use hospice care among Medicare decedents |
| Age — hospice use | Adults aged 85 and older most likely to use hospice; utilization increases with age |
| Geographic — hospice access | Significant variation by urban vs. rural location; rural patients face access limitations due to fewer certified providers |
| Majority of care setting | ~66% of hospice patients receive care at home — confirmed for 2023 and 2024 (Rosewood Nursing, 2025) |
| Most common diagnoses entering hospice (2022) | Dementia and Alzheimer’s disease — most prevalent individual diagnoses; cancer and circulatory disease most common category (~75% combined) |
| For-profit vs. nonprofit LOS | For-profit: 187 days; Nonprofit: 130 days — gap reflects patient mix and business model differences (MedPAC 2025) |
| For-profit hospice growth | Number of for-profit hospices grew in 2023 — continues long-term trend toward for-profit dominance |
| HCAP scores (quality measure) | Stable in most recent period — Hospice Consumer Assessment of Healthcare Providers and Systems |
| Process of care composite scores | Very high and topped out for most providers — limited ability to differentiate quality at current measurement level (MedPAC 2025) |
| Nurse visits — last days of life | Stable or slightly increased between 2022 and 2023 for patients on routine home care (MedPAC 2025) |
| Survivors beyond 6-month prognosis | Research (Journal of Palliative Medicine) indicates approximately 13.4% of hospice patients survive beyond their typical 6-month prognosis |
| Fewer than 10% | Of hospice patients live longer than 6 months — most consistent figure across research |
| Colorado, CA — leading hospice utilization states | Western states generally higher utilization; Southern states lower — geographic patterns well-documented in NHPCO data |
Source: America’s Health Rankings — Explore Hospice Care in the United States (AHR, accessed 2026; citing NHPCO Facts and Figures 2024 edition; Medicare data 2022); MedPAC — March 2025 Report to Congress Chapter 9: Hospice Services (MedPAC.gov); CMS Hospice Monitoring Report April 2025; National Alliance for Care at Home — 2025 Facts and Figures Executive Summary (March 3, 2026); Rosewood Nursing — Hospice Care Statistics (March 4, 2025)
The racial disparity in hospice utilization is one of the most documented and least resolved inequities in American end-of-life care. The gap between nearly half of White Medicare decedents who use hospice and only 1 in 3 Black Medicare participants who do so is not explained by differences in disease severity or terminal diagnosis rates — it is explained by a well-documented pattern of medical mistrust rooted in racism, including historical abuses of Black Americans by the medical system, fear that providers will deliver inadequate or dismissive care, and reduced exposure to palliative care conversations and education about available benefits. America’s Health Rankings, which aggregates data from NHPCO and Medicare, explicitly cites these factors as documented barriers, and the persistence of this gap despite decades of awareness campaigns underscores that awareness alone is insufficient — structural changes in how hospice is offered, who delivers it, and how communities of color are engaged are required.
The demographic profile of who uses hospice reveals a care model still concentrated among the oldest, most advantaged patients. Adults 85 and older are the highest utilizers, women are more likely than men to elect hospice, and White beneficiaries access it at far higher rates than any racial or ethnic minority group. The for-profit versus nonprofit length-of-stay gap — 187 days versus 130 days — remains a persistent concern in MedPAC’s analysis, reflecting both genuine patient mix differences and questions about whether the profit incentive in the daily payment system encourages for-profit providers to select patients with longer prognoses. Quality metrics, meanwhile, have largely plateaued: HCAP scores are stable, and process-of-care composite scores are so uniformly high across providers that they no longer function as meaningful quality discriminators — a measurement challenge that MedPAC explicitly calls out in its March 2025 report as requiring new metric development.
Disclaimer: The data research report we present here is based on information found from various sources. We are not liable for any financial loss, errors, or damages of any kind that may result from the use of the information herein. We acknowledge that though we try to report accurately, we cannot verify the absolute facts of everything that has been represented.
